IRCT20220423054621N1招募中3 期
Evaluation of the effect of oral eplerenone in the management of Acute Central Serous Chorioretinopathy
Bagheiat-allah University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Diagnosis of acute central serous chorioretinopathy before twelve weeks
- •Diagnosis of acute central serous chorioretinopathy for the first time
排除标准
- •Chronic CSCR (duration of visual symptoms more than 12 weeks)
- •Recurrent CSCR (patients with a history of one or more previous CSCR attacks)
- •Choroidal neovascularization (CNV) detected by FA, ??ICGA, or OCT angiography (OCT-A)
- •Any treatment for retinal disease (including intravitreal injections, photodynamic therapy, laser photocoagulation, vitrectomy)
- •History of other retinal disorders (including age-related macular degeneration, choroidal neovascularization, diabetic retinopathy, uveitis, or pathological myopia)
- •The presence of any other systemic disease for which eplerenone is contraindicated (such as severe renal, cardiac or hepatic failure, pregnancy, baseline serum potassium more than 0.5 mEq/L
- •simultaneous administration of potassium-sparing diuretics, potassium supplements, inhibitors angiotensin converting enzyme or angiotensin receptor blockers)
研究者
相似试验
招募中
1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCRCentral serous chorioretinopathyIRCT20220122053792N1Oroumia University of Medical Sciences34
进行中（未招募）
1 期
REMODEL-AMIEUCTR2014-005407-24-CZIKEM
已完成
不适用
Investigation of an efficacy of eplerenone combined therapy for hypertensive patients with chronic kidney disease that enough hypotensive effect are not obtained with an angiotensin receptor blockerHypertensive patients with chronic kidney disease that enough hypotensive effect is not obtained with an angiotensin receptor blockerJPRN-UMIN000005956OWASE study Project Office200
招募中
4 期
Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEBRO Study)Hypertension2024-519749-31-00Institute For Study Research Education And Therapy Of Vascular Heart Brain And Kidney Nosologies198
已完成
不适用
The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive PatientsHypertensive patients with cardiac diastolic dysfunction and preserved ejection fractionJPRN-UMIN000006415Graduate School of Medical Sciences, Kumamoto University180